FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to isoxazole derivatives of formula
and their pharmaceutically acceptable salts wherein X-Y is N-O or O-N; R1 is independently specified in a group consisting of halogen and C1-4alkyl; or two substitutes R1 together with carbon atoms whereto attached form a 6-member aromatic cycle; R2 represents hydroxy-C1-8alkyl; a is equal to 1, each of m and n is independently equal to 0, 1 or 2. Also, the invention refers to a pharmaceutical composition possessing type 1 11β-hydroxysteroid dehydrogenase inhibitory activity and containing the compounds of formula (I), to the use of the mentioned compounds for producing a drug preparation for treating or preventing glaucoma, as well as to a method of treating glaucoma.
EFFECT: compounds of formula (I) as type 1 11β-hydroxysteroid dehydrogenase inhibitors.
9 cl, 2 dwg, 28 ex
Title | Year | Author | Number |
---|---|---|---|
NEW PIPERAZINE AMIDE DERIVATIVES | 2008 |
|
RU2454412C2 |
SUBSTITUTED PYRROLIDIN-2-CARBOXAMIDE | 2011 |
|
RU2564022C2 |
DERIVATIVES OF CARBOXYLIC ACIDS (VARIANTS), PHARMACEUTICAL COMPOSITION AND METHOD FO SELECTIVE BINDING αβ-INTEGRIN IN MAMMAL | 2000 |
|
RU2263109C2 |
DERIVATIVES OF [1,2,3]TRIAZOLO[4,5-D]PYRIMIDINE WITH AFFINITY TO CANNABINOID RECEPTORS OF TYPE 2 | 2017 |
|
RU2741597C2 |
PYRROLIDINE DERIVATIVES | 2010 |
|
RU2562605C2 |
DERIVATIVES OF NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS, METHODS FOR THEIR PREPARING, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHODS FOR TREATMENT OF INFLAMMATORY DISEASES AND RESPIRATORY WAYS DISEASES | 2001 |
|
RU2265011C2 |
3-AMINOPYRROLIDINE DERIVATIVES AS CHEMOKINE RECEPTOR MODULATORS | 2003 |
|
RU2355679C2 |
GEMINALLY SUBSTITUTED CYANOETHYLPYRAZOLO PYRIDONES AS JANUS KINASE INHIBITORS | 2014 |
|
RU2664533C2 |
CONDENSED TRICYCLIC BENZIMIDAZOLE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | 2014 |
|
RU2689777C1 |
AZASPIROALKANE DERIVATIVES METALLOPROTEASE INHIBITORS | 2004 |
|
RU2379303C2 |
Authors
Dates
2013-04-27—Published
2009-01-16—Filed